Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Posted by Someuwin on ADVFN http://www.apfoodonline.com/index.php/ph3/item/1685-optibiotix-prebiotic-fibres
OptiBiotix Health PLC Q&A with CEO Stephen O’Hara (LON:OPTI) Posted by: Amilia Stone 17th August 2017 OptiBiotix Health PLC (LON:OPTI) Chief Executive Officer Stephen O’Hara caught up with ************* for an exclusive interview to discuss the recent share price movement, their deal pipeline, the 39 potential RNS’s that could be announced in the following months & what this all means for investors Q1: Just recently, there’s been a fall in OptiBiotix Health’s share price, how would you explain the share price performance? A1: There has been some volatility in the share price, the first thing I wanted to do was to reassure investors that there’s nothing wrong. If you look back at where we are now to where we were say 12 months or so ago, the share price was higher 12 months or so ago but undoubtedly, we’re in a stronger position today than we were when the share price was trading at 80p. Even more importantly, if we look towards the future, there are a lot more opportunities we are progressing which are at a later stage, we touched on in previous RNS’s, and are entering the commercialisation phase. We do recognise there is uncertainty in small caps in general, and that’s across the board, and we do have a large retail investor base so we will get peaks and troughs, some shareholders just take profit and there’s also some uncertainty in the external environment which means that some retail investors start to take a shorter view. I would say that if you look at where we are with the company, we’ve just entered a commercialisation and I believe this next stage of growth, there’s a potential for share growth which will come when we gain commercial traction with our products. Based on the high level of interest and lots of ongoing discussions, this look extremely promising and investors who attended my investor share results presentation earlier on in the year will recognise we have a structured plan and that’s the reason we appointed a new Commercial Director, Per Rehné and a new Sales Director in January 2017. They joined us at the end of March and as planned, we launched products in May and as I reported in previous RNS’s, there’s been a lot of interest, extensive interest, from our launch of Vitafoods in the middle of May, we’ve been working hard to close out deals from those discussions. We have closed out 2 deals, one with HLH and one with Pharmabiota, both these are privately-owned pharmaceutical companies so they are far quicker in decision making. As people are also aware, HLH they had an initial order of 100,000 and last week they ordered another 200,000 units so you can see that it’s not just signing deals, HLH for example signed a deal, put the products on the market and now re-ordered twice the number of units they ordered initially. We have a number of agreements in our pipeline, 4 private companies like
. We hope this will be the first of many product launches of multiple formulations and presentations of LPLDL® as the active component in a wide range of pharmaceutical and consumer products around the world. WORLD DYOR & GLA
Yet s/p not moving.....?
Well that probably explains the share price in limbo of late under very tight bid / ask prices. Hopefully the s/p will be more realitic now as I've just seen above the bid/ask price has a better spread. Just my thoughts... DYOR & GLA
heyhoe...another flat line day. At least this share pays a dividend, that's a bonus!
As you've said yourself, Those figures are back to November , early days! Groupon I think great idea. Do you know how many subscribe to that website and priority buys are, I reckon, directed at beauty and diet market given the selfie generation we have these days we've never had folk be so body conscious. Give folk a taster , and then they will buy the product full price = more converts to a diet that actually works. Think of the royalties... So IMHO, it's a good move. Don't forget we sell down south in stores and over in Iceland, ( the country ) now.... GLA and DYOR
I think we've flat lined? Any idea folks? Can't understand it considering great last RNS and recently tipped....
Are played like a flipping fiddle here! Talk about walking the price up or down, Small trades most of the time yet s/p jumps by whole percent on a couple of trades.. Still got faith in the company but this s/p dismal...
I'm happy with that, broader spectrum of customers / prices....
Top investor reveals two UK small-caps that are ‘exciting opportunities’ right now www.whatinvestment.co.uk/top-investor-reveals-two-uk-small-caps-exciting-opportunities-right-now-2553759/
Look at the buy v sells column. I'm wondering if an RNS is due soon on the back of that, hoping it's more institutions buying in. Just bought in myself today under 60 and delighted this share seems to be gently easing up daily. Plus it's my first AIM share that pays dividends ! GLA & DYR
Posted by Parob on Avfn board today New phone interview just out! hTTp://www.***************************/interview-optibiotix-health-plc-exciting-time-investors/412727094 INTERVIEW: OptiBiotix Health Plc – An exciting time for investors OptiBiotix Health Plc (LON:OPTI) CEO Stephen O’Hara talks to ************* about the listing of SkinBiotheraputics (LON:SBTX). Stephen explains the rationale behind the launch, what this could mean for OptiBiotix investors, the timing involved and how this all fits into the company strategy.
I particularly liked these paragraphs..... Materialising value for shareholders is the mantra for the boss of life sciences firm Optibiotix PLC " The firm’s boss also said he plans to give some more of the value from the SkinBio float back to Opti shareholders in the future as well, in a way that is best for both firms. Overall, O’Hara’s aim is to further the commercialisation phase of the business, increasing revenues organically, but is also exploring the opportunity to make a strategic acquisition as well, which may be the only reason for the firm to raise any further cash, give its healthy balance sheet. Certainly, Opti has provided shareholders with value, with the stock having jumped to a level of around 80p today against a flotation price in August 2014 of 8p a share. If its boss can deliver on his plans that value could be very much enhanced. " http://www.proactiveinvestors.co.uk/companies/news/176222